5 January 2022
| Kathryn Ball, Jonathan Charles Goddard
|
URO - Core Urology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). This month, I am joined by Kassie Ball, a urology trainee, who approached...
There have been some exciting developments in bladder cancer over the last few years. Immunotherapy has prolonged survival in a proportion of patients with metastatic disease, with sustained efficacy in some. Advances in genetic analysis and molecular subtyping make personalised...
This year saw the launch of the first Urology News Imaging Competition, sponsored by Karl Storz UK. We were delighted to receive a large and diverse range of entries with a wide interpretation of the brief, showcasing that there really...
Paediatric urology training A review of paediatric emergency services in the UK involving general surgery, urology and paediatric surgery was initiated due to the problems encountered by the lack of suitable experience outside large paediatric surgical units to deliver emergency...
Professor Christopher Chappel. Prof Chapple, thank you for taking the time to chat with the Urology News team. Can we start by asking about your background and how you ended up in the field of urology? Early in my career...
Current exposure to urology in medical undergraduate curriculums is relatively sparse in comparison to the other surgical specialties with one study reporting just 42% of students having a compulsory attachment. These attachments were an average length of just one week...
This is a prospective study evaluating the tolerability and efficacy of transcutaneous posterior tibial nerve stimulation (TPTNS) in patients with urodynamically proven overactive bladder (OAB), who have failed anticholinergic treatment. Forty-three patients were studied and followed up over a period...
Wellspect’s revolutionary new female catheter has added another award to its list of accolades. The 'Look Good, Feel Good' award, which is a joint initiative of Bladder and Bowel UK and the...
Action Bladder Cancer UK (ABC UK) will open applications in November 2024 for its 2026 research funding programmes, supporting projects that improve the care, treatment, or diagnosis of bladder cancer. Grants are offered under two schemes. The Improving Outcomes for...
Active surveillance is a major treatment option for patients with favourable prognosis prostate cancer, such as those regarded as Cambridge Prognostic Group (CPG) 1 and 2 [1]. The rationale for this management strategy is the lack of survival benefit from...